Portfolio company
Oncoradiomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech firm develops AI-powered image analysis software for pharmaceutical companies and clinicians to improve cancer diagnostics and treatment evaluation through quantitative imaging data.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AIQ Solutions
The company develops medical imaging software to help clinicians and pharmaceutical firms manage late-stage cancer and evaluate treatment response.
RADiCAIT
This company develops artificial intelligence software that converts standard CT scans into functional PET-like images for radiologists and oncologists.
Quibim
This company develops AI-powered medical imaging software to extract biomarkers for biopharma companies and healthcare providers to improve disease diagnosis and clinical trials.
Oncoustics
This company develops AI-powered software that analyses raw ultrasound signals for non-invasive liver disease diagnostics and tissue characterisation for clinics and pharmaceutical partners.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Synaptiq
This company develops artificial intelligence software for medical imaging to assist radiotherapy clinics with tumor and organ delineation for cancer treatment planning.
Deeplook Medical
This company develops image analysis software for radiologists to improve the measurement and visualisation of suspicious masses within medical imaging scans.
DoMore Diagnostics
This company develops artificial intelligence software for digital pathology to help oncologists and pathologists provide personalised cancer treatment paths for patients.
